Real-time continuous glucose monitoring using Guardian®RT: from research to clinical practice

Diabetes and Metabolism

Volumn 33, Issue 6, 2007, Pages 415-420

  Tubiana Rufi, N ^a   Riveline, J P ^b   Dardari, D ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b CENTRE HOSPITALIER SUD FRANCILIEN   (France)

Author keywords

Blood glucose monitoring; Continuous glucose monitoring; Diabetes; Review; Sensors

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

BLOOD GLUCOSE MONITORING; CALIBRATION; CLINICAL PRACTICE; CLINICAL RESEARCH; DEVICE; DIABETES MELLITUS; DIABETIC PATIENT; FOOD INTAKE; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MONITOR; PHYSICAL ACTIVITY; SENSOR; SHORT SURVEY; TELEMETRY;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; HUMANS; MONITORING, AMBULATORY; SENSITIVITY AND SPECIFICITY;

EID: 36749003852     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2007.05.003     Document Type: Short Survey

References (19)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
2. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: diabetes control and complications trial. J. Pediatr. 125 (1994) 177-188
3. Haller M.J., Stalvey M.S., and Silverstein J.H. Predictors of control of diabetes: monitoring may be the key. J. Pediatr. 144 (2004) 660-661
4. Boland E., Monsod T., Delucia M., Brandt C.A., Fernando S., and Tamborlane W.V. Limitations of conventional methods of self-monitoring of blood glucose. Lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 24 (2001) 1858-1862
5. Kaufman F.R., Gibson L.C., Halvorson M., Carpenter S., Fisher L.K., and Pitukcheewanont P. A pilot study of the continuous glucose monitoring system. Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 24 (2001) 2030-2034
6. Ludvigsson J., and Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 111 (2003) 933-938
7. Schaepelynck-Belicar P., Vague P., and Lassmann-Vague V. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). Diabetes Metab. 29 (2003) 608-612
8. Chico A., Vidal-Rios P., Subira M., and Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 26 (2003) 1153-1157
9. Diabetes Research in Children Network (DirecNet) Study Group. A randomized multicenter trial comparing the GlucoWatch G2 Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 28 (2005) 1101-1106
10. Deiss D., Bolinder J., Riveline J.P., Battelino T., Bosi E., Tubiana-Rufi N., et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 29 (2006) 2730-2732
11. Guerci B., Floriot M., Bohme P., Durain D., Benichou M., Jellimann S., et al. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 26 (2003) 582-589
12. Diabetes Research in Children Network (DIRECNET) Study Group. The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. Diabetes Technol. Ther. 5 (2003) 781-789
13. Bode B., Gross K., Rikalo N., Schwartz S., Wahl T., Page C., et al. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol. Ther. 6 (2004) 105-113
14. Clarke W.L., Anderson S., Farhy L., Breton M., Gonder-Frederick L., Cox D., et al. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 28 (2005) 2412-2417
15. Monsod T.P., Flanagan D.E., Rife F., Saenz R., Caprio S., Sherwin R.S., et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia?. Diabetes Care 25 (2002) 889-893
16. Direct Net Study Group. Evaluation of factors affecting CGMS calibration. Diabetes Technol Therap 8 (2006) 318-325
17. Garg S.K., Schwartz S., and Edelman S.V. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 27 (2004) 734-738
18. Weinzimer S.A., Steil G.M., Kurtz N., Swann K.L., and Tamborlane W.V. Automated feedback-controlled insulin delivery in children with type 1 diabetes mellitus (T1D): a preliminary report. Diabetes 55 suppl1 (2006) A102 (A)
19. Steil G.M., Rebrin K., Darwin C., Hariri F., and Saad M.F. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 55 (2006) 3344-3350